Journal
DISEASE MODELS & MECHANISMS
Volume 8, Issue 9, Pages 1105-1119Publisher
COMPANY BIOLOGISTS LTD
DOI: 10.1242/dmm.019927
Keywords
Integrin; Neuropilin-1; Angiogenesis; Tumour; Focal adhesion
Categories
Funding
- BigC PhD studentship
- BBSRC DTP PhD studentship
- UEA Dean's PhD studentship
- UEA's School of Biological Sciences
- John and Pamela Salter Trust [DFGSCH682/3-1]
- FNR Core ITGB3 VascIn funding
- European Union
- Biotechnology and Biological Sciences Research Council [1367881] Funding Source: researchfish
Ask authors/readers for more resources
Anti-angiogenic treatments against alpha v beta 3-integrin fail to block tumour growth in the long term, which suggests that the tumour vasculature escapes from angiogenesis inhibition through alpha v beta 3-integrin- independent mechanisms. Here, we show that suppression of beta 3-integrin in mice leads to the activation of a neuropilin-1 (NRP1)-dependent cell migration pathway in endothelial cells via amechanism that depends on NRP1' s mobilisation away from mature focal adhesions following VEGF-stimulation. The simultaneous genetic targeting of both molecules significantly impairs paxillin-1 activation and focal adhesion remodelling in endothelial cells, and therefore inhibits tumour angiogenesis and the growth of already established tumours. These findings provide a firm foundation for testing drugs against thesemolecules in combination to treat patients with advanced cancers.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available